Cilnidipine
Article about the calcium channel blocker Cilnidipine
| Cilnidipine | |
|---|---|
|
|
Cilnidipine is a calcium channel blocker used in the management of hypertension. It is a dual blocker of L-type and N-type calcium channels, which makes it unique among calcium channel blockers.
Pharmacology[edit]
Cilnidipine is a dihydropyridine calcium channel blocker. It works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and a reduction in blood pressure. The dual action on L-type and N-type calcium channels provides additional benefits in terms of reducing sympathetic nerve activity.
Mechanism of Action[edit]
Cilnidipine blocks L-type calcium channels, which are primarily found in the vascular smooth muscle and the heart. This action leads to vasodilation and decreased peripheral resistance. Additionally, cilnidipine blocks N-type calcium channels, which are located in the sympathetic nervous system. This reduces the release of neurotransmitters such as norepinephrine, further contributing to its antihypertensive effects.
Clinical Use[edit]
Cilnidipine is primarily used for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. The dual action on both L-type and N-type calcium channels makes it particularly effective in patients with high sympathetic nerve activity.
Side Effects[edit]
Common side effects of cilnidipine include dizziness, flushing, headache, and peripheral edema. These are typical of calcium channel blockers due to their vasodilatory effects. Rarely, it may cause bradycardia or hypotension.
Dosage and Administration[edit]
Cilnidipine is administered orally, usually once daily. The dosage may vary based on the patient's response and the severity of hypertension. It is important to follow the prescribing physician's instructions and not to discontinue the medication abruptly.
Related pages[edit]
-
Cilnidipine
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian